Abrilumab (MEDI-7183) is a fully human monoclonal antibody against alpha4beta7 that inhibits the alpha4beta7 integrin and can be used to study inflammatory bowel disease and ulcerative colitis.
Purity:
98.50%
CAS Number:
[1342290-43-0]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted